Technologists are getting better at coding biology and venture firms are flooding a new generation of startups with cash so that they can commercialize their technology bringing in the next wave of genetic innovation. Tessera Therapeutics, the Boston-based spinup from Flagship Pioneering, is the latest company to enter the mix with $230 million in new […]...